Filter
504
Filtered Results: 504
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
68
New Publications
105
Language
Document type
No document type
232
Guidelines
130
Studies & Reports
60
Manuals
45
Strategic & Response Plan
14
Fact sheets
14
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
26
Germany
15
Global
12
Latin America and the Carribbean
12
South Africa
11
Africa
10
Western and Central Europe
10
Kenya
7
Russia
7
Tanzania
6
Rwanda
5
Brazil
5
Ethiopia
5
Cameroon
4
Nigeria
4
Eastern Europe
4
Namibia
4
Nepal
3
Senegal
3
Congo-Brazzaville
3
Burkina Faso
3
Malawi
3
West and Central Africa
3
Uganda
3
Zambia
3
Ukraine
2
Benin
2
Sierra Leone
2
Togo
2
Niger
2
Haiti
2
Asia
2
Venezuela
2
Congo, Democratic Republic of
2
Middle East and North Africa
2
France
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Bangladesh
2
Mali
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Colombia
1
Turkey
1
Gambia
1
Chile
1
Syria
1
Albania
1
Canada
1
Laos
1
Burundi
1
Peru
1
Zimbabwe
1
Philippines
1
Guinea
1
USA
1
South–East Asia Region
1
Luxembourg
1
North America
1
Belgium
1
Southern Africa
1
Bolivia
1
Djibouti
1
Yemen
1
Angola
1
South Sudan
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
50
Policies & Guidelines HIV & TB
29
COVID-19
28
TB
22
Drugs & Medical Equipment
19
Hepatitis
14
Pediatrics
13
HIV & STI
13
Medical Devices & Equipment
11
Virology
10
Parasitology
9
Malaria
9
Policies
8
Disease Prevention & Control
8
Paediatrics
7
Vaccine-preventable Diseases
7
Studies & Reports
7
Buruli Ulcer
6
Bacteriology
6
Capacity Building
6
Reproductive Health
6
Women & Child Health
5
Quality Control & Assurance
5
General Guidelines
4
Gynaecology & Obstetrics
4
Neonatal Care
4
Communicable Diseases
3
Hematology
3
Cancer
3
Cervical Cancer
3
Yersinia pestis (Plague)
3
Countries
3
Diarrhoeal Disease/Cholera
3
NTDs & Others
3
Maternal Health
3
Digital Health
2
Rabies
2
Emergency Health Kits
2
Lymphaticfilariasis
2
Monitoring & Evaluation
2
Cancer Treatment & Resources
2
Infection Control & Prevention (IPC)
2
Snakebites
2
Humanitarian Crisis
2
Immunization
2
Communicable Diseases
2
Health Systems
2
Laboratory Quality Assurance
2
Zika
1
Dental & Eye Care
1
Helminthiasis
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Hand Hygiene
1
Disaster Preparedness
1
Schistosomiasis
1
Vector Control
1
MPOX - Monkeypox
1
Cardiovascular Diseases
1
Clinical Guidelines
1
Yellow Fever
1
Community Health
1
Disabilities
1
Women & Child Health
1
Primary Health Care
1
Dengue
1
Leishmaniasis
1
Non-communicable Diseases
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Diagnostics & Laboratory Guidance
24
Testing Guidelines
21
HIV testing & services
18
Clinical Guidelines
17
Laboratory
16
Drug resistant TB
16
Detection & Diagnosis
15
Country specific documents
14
Adults
10
Children
9
Research & Access
8
Germany
8
Surveillance & Contact tracing
7
Hospital Readiness/Essential Health Services
7
Clinical Aspects & Diagnostics
7
Clinical Aspects, Treatment & Prevention
6
Country specific
6
Global Impact: Socio-economic, health services, TB & HIV
6
Surveillance
5
Prevention & Control
5
Hepatitis
5
Public Health
5
Essential Medicines & Medical Devices
5
SARS-CoV-2 Variants
5
Policies & Strategies
4
Children & Adolescents
4
Treatment Guidelines HIV
4
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
4
Laboratory & Sampling
4
Studies
4
General
4
Infection Control General
4
Scientific & Research Studies
4
Genomic sequencing
4
Traditional & Herbal Medicines
4
MPOX - Monkeypox
4
Access to treatment and laboratory
4
Antiretroviral Treatment ART
4
TB
4
Outbreak Prevention & Control
3
Gynaecology / Obstetrics
3
ART Drug Resistance
3
Childhood TB
3
Laboratory Guidance
3
Agriculture & Veterinary
3
Ebola Prevention & Control
3
Surveillance
3
Treatment & Prevention
3
Vaccines & Immunization
3
Children/Adolescents Mental Disorders
3
Vaccination
3
Prevention & Preparedness
3
Health Personnel
3
Clinical Aspects
3
Public Health
3
PPE Personel Protective Equipment
3
Clinical Guidelines
3
Appeals and Response Plans
3
Oxygen Therapy
3
Quality Assurance
3
Rational use of Medicine
3
Training
3
Stewardship
3
Clinical Guidelines
3
TB/HIV Coinfection
3
Preparedness & Prevention
3
Laboratory & Diagnostics
3
Reports & Studies
3
Eastern Europe and central Asia
3
Plague Prevention & Control
3
Preparedness & Prevention
3
Yellow Fever Prevention & Control
2
Opportunistic Infections
2
Laboratory
2
Cholera Prevention & Control
2
Research
2
Ethiopia
2
International
2
General
2
Supporting tools
2
Context & Facts, Travel Advice
2
Overview & reports
2
Essential Medicines
2
Essential Medicines & Devices Lists
2
Falsified & Substandard
2
Supply Chain & Store Management
2
HIV &TB
2
Emergency health kits
2
Emergency health kits
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Leptospirosis
2
Snakebite envenoming
2
Asia and Pacific
2
TB & Prisoners
2
Disease Prevention & Control
2
Dengue Prevention & Control
2
Zika Prevention & Control
2
Paediatrics
2
Capacity Building
2
Alcohol
1
Treatment Guidelines
1
Assessment & Studies
1
Meningitis Prevention & Control
1
IPC
1
Background PTSD in children
1
Europe
1
Clinical Aspects
1
Clinical Guidelines
1
Influenza Prevention & Control
1
HIV surveillance
1
Plague
1
Policies
1
Infection Control
1
HIV testing & disclosure
1
Clinical Guidelines
1
Transgender People
1
Namibia
1
Drug resistance
1
Eastern Europe
1
Surveillance
1
TB
1
Prophylaxis
1
Ebola
1
Human Rights
1
Posttraumatic Stress Disorder in Children
1
Reports
1
Russia
1
Key Resources
1
Context & Facts
1
Treatment Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Livestock production
1
Infection Prevention & Hygiene
1
Essential List
1
Hand Hygiene
1
Covid-19 & the One Health Approach
1
For Pregnant Women
1
Training, others
1
Faith-based Organizations
1
Country Specific
1
Paediatrics
1
Physical Distancing
1
Situation Reports COVID-19
1
Non-pharmaceutical interventions (NPIs)
1
TB/HIV
1
Preparedness, Response & Risk Communication
1
Fair Allocation & Ethical Aspects
1
TB/COVID-19
1
Biontech/Pfizer Comirnaty
1
Research & Pipeline
1
Hygiene
1
Hand Hygiene
1
Primary Care
1
Ethics
1
Pharmacy Practice
1
Resuscitation
1
General documents One Health
1
Argentina
1
General Guidelines for Rational Use
1
Pharmacovigilance
1
Capacity Building
1
Guidelines & Manuals
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Prevention & Control
1
Patient Safety
1
Overview, Studies & Reports
1
Echinocccosis
1
Mycetoma, Chromoblastomycosis & other deep mycosis
1
Yaws & other Endemic Treponematoses
1
Prevention & Strategies
1
Prevention & Control
1
Clinical Guidelines
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Children's Rights
1
General
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Malawi
1
One Health
1
Prophylactic Treatment
1
Tuberculosis
1
Technical Information
1
Roadmaps, Action Plans & Policies
1
Situation Reports
1
Assessment
1
HIV and coinfection
1
Clinical Guidelines
1
Others
1
Anxiety Disorders
1
HIV service delivery
1
AmR (Region of Americas)
1
South-east Asia Region
1
Laboratory
1
Reports & Studies Children HIV
1
Context & Facts
1
Marburg Virus Situation Reports
1
HIV in Key Populations
1
Eastern Europe & Central Asia
1
Action Plans, Policies & Response
1
Depression
1
Pregnant women
1
Meningitis & Encephalitis
1
Public Health
1
SEAR (South-east Asia Region)
1
Global Burden of Disease
1
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ...
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the management and diagnosis of infectious diseases, including malaria, HIV and COVID-19. Visually interpreted RDTs, more than any other class of diagnostics, fulfil WHO’s ASSURED criteria,1 enabling their...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid diagnostic tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distingu...
Laboratory diagnosis of Buruli ulcer
recommended
A manual for health care providers.
This manual provides expert guidance on the laboratory techniques and procedures used in the diagnosis of Buruli ulcer, a disease caused by Mycobacterium ulcerans. Aimed at laboratory technicians and scientists working on this disease, the manual details the exac...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This policy guideIine is intended for use by healthcare professionals invoIved in the management of Covid-19 in South Africa. The document provides guidance on diagnostic tests available, on antigen test performance and accessibility. 1t focuses on key issues such as when to
Perform antigen tests...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance includes a step-by-step process to be followed after the...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
